Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and AustraliaAdriano Lazzarin, Miklos Salgo, Bonaventura Clotet et al.|New England Journal of Medicine|2003Cited by 653
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trialAli Abbara, Waljit S. Dhillo, Deborah Papadopoulou et al.|Human Reproduction|2017Cited by 69
Risk of Ovarian Cancer Relapse ScoreIvana Rizzuto, Sarah P. Blagden, Chara Stavraka et al.|International Journal of Gynecological Cancer|2015Cited by 52